Evidence map

ReviewThe Annals of pharmacotherapy2014

Dapagliflozin for the Treatment of Type 2 Diabetes Mellitus.

Andrew Aylsworth et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2014
2015
2016
2017
2018
2019
2020
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 24951310